Literature DB >> 24170961

Clinicopathologic characteristics and prognosis of advanced gastric cancer simulating early gastric cancer.

Hiroaki Saito1, Kozo Miyatani, Seigo Takaya, Tomoyuki Matsunaga, Yoji Fukumoto, Tomohiro Osaki, Toshiro Wakatsuki, Masahide Ikeguchi.   

Abstract

BACKGROUND: Although the clinicopathologic features and prognosis of Borrmann type advanced gastric cancer has been well characterized, those of advanced gastric cancer simulating early gastric cancer (AGC simulating EGC) still remains unclear.
METHODS: We reviewed 1985 gastric cancer patients who had undergone gastrectomy at our hospital to determine the clinicopathologic characteristics, susceptible sites for lymph node metastasis, and prognosis of AGC simulating EGC in comparison with Borrmann type advanced gastric cancer.
RESULTS: Among 102 patients with AGC simulating EGC, 100 patients (98%) had tumors with depressed type appearance. The frequencies of serosal invasion, lymph node metastasis, lymphatic vessel invasion, blood vessel invasion, and liver metastasis were significantly lower in AGC simulating EGC than in Borrmann type tumors. The prognosis of AGC simulating EGC was significantly better than that of the Borrmann type tumors. Multivariate analysis indicated that the gross appearance was an independent prognostic factor. In patients with AGC simulating EGC which invaded to the the muscularis propria (MP), most lymph node metastasis was restricted with the perigastric lymph nodes (1st-titer lymph nodes) and lymph node metastasis to 2nd-titer lymph nodes was only observed at station 8a.
CONCLUSION: AGC simulating EGC is less advanced in comparison with Borrmann type advanced gastric cancer. Based on the results of susceptible sites for lymph node metastasis in the current study, limited lymph node dissection could be indicated for AGC simulating EGC whose depth of invasion is MP.

Entities:  

Keywords:  gastric cancer; gross appearance; lymph node dissection; prognosis

Year:  2013        PMID: 24170961      PMCID: PMC3809722     

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  18 in total

1.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

2.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  Progress in gastric cancer surgery in Japan and its limits of radicality.

Authors:  K Maruyama; K Okabayashi; T Kinoshita
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

4.  Endoscopic ultrasonography and endoscopy for staging depth of invasion in early gastric cancer: a pilot study.

Authors:  H Yanai; Y Matsumoto; T Harada; M Nishiaki; H Tokiyama; T Shigemitsu; M Tada; K Okita
Journal:  Gastrointest Endosc       Date:  1997-09       Impact factor: 9.427

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.

Authors:  Takuji Gotoda; Akio Yanagisawa; Mitsuru Sasako; Hiroyuki Ono; Yukihiro Nakanishi; Tadakazu Shimoda; Yo Kato
Journal:  Gastric Cancer       Date:  2000-12       Impact factor: 7.370

7.  Lymph node metastasis and preoperative diagnosis of depth of invasion in early gastric cancer.

Authors:  Y Seto; S Shimoyama; J Kitayama; K Mafune; M Kaminishi; T Aikou; K Arai; K Ohta; A Nashimoto; I Honda; H Yamagishi; Y Yamamura
Journal:  Gastric Cancer       Date:  2001       Impact factor: 7.370

8.  Clinicopathological features of patients with Borrmann type IV gastric carcinoma.

Authors:  Dong Yi Kim; Hyeong Rok Kim; Young Jin Kim; ShinKon Kim
Journal:  ANZ J Surg       Date:  2002-10       Impact factor: 1.872

9.  Advanced gastric carcinoma simulating early gastric carcinoma.

Authors:  M Mori; Y Adachi; K Nakamura; S Kuroiwa; M Enjoji; K Sugimachi
Journal:  Cancer       Date:  1990-02-15       Impact factor: 6.860

10.  Clinicopathologic study of patients with Borrmann type IV gastric carcinoma.

Authors:  K Kitamura; R Beppu; H Anai; K Ikejiri; S Yakabe; K Sugimachi; M Saku
Journal:  J Surg Oncol       Date:  1995-02       Impact factor: 3.454

View more
  2 in total

1.  A comprehensive evaluation of clinical efficacy and safety of celecoxib in combination with chemotherapy in metastatic or postoperative recurrent gastric cancer patients: A preliminary, three-center, clinical trial study.

Authors:  Qinghong Guo; Qiang Li; Jiong Wang; Min Liu; Yuping Wang; Zhaofeng Chen; Yuwei Ye; Quanlin Guan; Yongning Zhou
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

2.  Difficulty in distinguishing malignant gastric lymphoma from advanced gastric cancer: Focusing on endoscopic findings of the Borrmann type.

Authors:  Kyoungwon Jung; Il Hyeong Choe; Moo In Park; Seun Ja Park; Won Moon; Sung Eun Kim; Jae Hyun Kim; Kwang Il Seo
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.